Is OKUR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OKUR. It does not provide personalized investment advice.

OKUR (OnKure Therapeutics, Inc. Class A Common Stock) Stock Analysis - Financials

OnKure Therapeutics, Inc. Class A Common Stock (OKUR) is a publicly traded Healthcare sector company. As of September 21, 2026, OKUR trades at $3.01 with a market cap of $119.46M and a P/E ratio of -0.67. OKUR moved +0.34% today. Year to date, OKUR is +1.72%; over the trailing twelve months it is +18.95%. Its 52-week range spans $1.70 to $6.48. Analyst consensus is strong buy with an average price target of $17.00. Rallies surfaces OKUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are OKUR's key financials?

OKUR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OKUR recently traded at $3.01. Market cap is $119.46M. P/E ratio is -0.67. Revenue is $3.43M.

OKUR Key Metrics

Key financial metrics for OKUR
Metric	Value
Price	$3.01
Market Cap	$119.46M
P/E Ratio	-0.67
EPS	$-4.40
Dividend Yield	0.00%
52-Week High	$6.48
52-Week Low	$1.70
Volume	85.61K
Avg Volume	0
Revenue (TTM)	$3.43M
Net Income	$-59.52M
Gross Margin	0.00%

OKUR Analyst Consensus

4 analysts cover OKUR: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.00.

Common questions about OKUR

What are OKUR's key financials?: OKUR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OKUR recently traded at $3.01. Market cap is $119.46M. P/E ratio is -0.67. Revenue is $3.43M.
Is OKUR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OKUR. It does not provide personalized investment advice.